The autoactivation of p38α MAPK through TAB1 was observed in pathological conditions, including cardiac ischemia and heart failure and has been shown to aggravate myocardial injury (De Nicolaet al., 2018;Liet al., 2005;Shiet al., 2010;Tannoet al., 2003). This evidence concerns the gene TAB1 and heart failure.